Search - tctmd.com

Displaying 1 - 20 of 77

Sort: Relevancy | Date

News Conference News ISC 2026

CHOICE-2 Bolsters Intra-arterial Lytics After Stroke Thrombectomy

Todd Neale

February 06, 2026

News Opinion CV Team Dispatch

January 2026 Dispatch for the CV Team

L.A. McKeown

January 16, 2026

News Opinion CV Team Dispatch

October 2025 Dispatch for the CV Team

L.A. McKeown

October 25, 2025

News Daily News

High Aerobic Fitness Linked to Less Chronic Disease in Later Life

Michael O'Riordan

October 10, 2025

News Daily News

Recognize and Enable Care for Post-MI Psychological Distress: AHA

L.A. McKeown

October 01, 2025

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Opinion CV Team Dispatch

July 2025 Dispatch for the CV Team

L.A. McKeown

July 24, 2025

News Conference News ACC 2025

FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints

L.A. McKeown

April 03, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

News Daily News

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Michael O'Riordan

February 24, 2025

News Daily News

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Yael L. Maxwell

February 20, 2025

News Conference News AHA 2024

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

Michael O'Riordan

November 16, 2024

News Conference News ESC 2024

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

Michael O'Riordan

September 02, 2024

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

L.A. McKeown

May 17, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Conference News

Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality

Michael O'Riordan

March 22, 2024

News Daily News

Erectile Dysfunction Drugs Don’t Mix Well With Nitrates After MI, PCI

Todd Neale

January 16, 2024

News Daily News

Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk

Todd Neale

December 12, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Opinion CV Team Dispatch

September 2023 News Roundup

L.A. McKeown

September 01, 2023

Advertisement

CHOICE-2 Bolsters Intra-arterial Lytics After Stroke Thrombectomy

January 2026 Dispatch for the CV Team

October 2025 Dispatch for the CV Team

High Aerobic Fitness Linked to Less Chronic Disease in Later Life

Recognize and Enable Care for Post-MI Psychological Distress: AHA

CVD Still the Leading Cause of Death and Disease Globally

July 2025 Dispatch for the CV Team

FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality

Erectile Dysfunction Drugs Don’t Mix Well With Nitrates After MI, PCI

Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

September 2023 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content